InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Discover the full record of transactions filed by COHEN RAYMOND W, Chairman & CEO. Officer active across 2 companies, notably Axonics, Inc.. Aggregated, 14 reports have been published. Total volume traded: €17.4m. The latest transaction was disclosed on 29 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
€3m50,000 shares@ €54.095415.5% of flow
Common Stock
SEC:0001562180-22-003045:0·
€820,33217,787 shares@ €46.11974.7% of flow
Common Stock
SEC:0001562180-22-002687:0·
043,297 shares0
Common Stock
SEC:0001562180-22-001104·
043,297 shares0
Common Stock
SEC:0001562180-22-001104:0·
€3m50,000 shares@ €65.201746.9% of flow
Common Stock
SEC:0001562180-21-005938·
€3m50,000 shares@ €65.201718.7% of flow
Common Stock
SEC:0001562180-21-005938:0·
5,000 shares
Common Stock
SEC:0001437749-21-016942·
5,000 shares
Common Stock
SEC:0001437749-21-016942:0·
€2m33,333 shares@ €49.2923.6% of flow
Common Stock
SEC:0001562180-21-004197·
€2m33,333 shares@ €49.299.4% of flow
Common Stock
SEC:0001562180-21-004197:0·
€1m32,833 shares@ €44.993521.2% of flow
Common Stock
SEC:0001562180-21-003684·
€1m32,833 shares@ €44.99358.5% of flow
Common Stock
SEC:0001562180-21-003684:0·
€572,06113,109 shares@ €43.63888.2% of flow
Common Stock
SEC:0001562180-21-003441·
€572,06113,109 shares@ €43.63883.3% of flow
Common Stock
SEC:0001562180-21-003441:0·
14 of 14 declarations
About COHEN RAYMOND W
Raymond W. Cohen is Chairman & CEO of Axonics, Inc. and BIOLIFE SOLUTIONS INC. With extensive experience in business management, he leads operations and develops strategies to foster growth and innovation within both companies.
